Method for treating myopia

Through the combined use of topiracamide eye drops and rosuvastatin calcium tablets, the problems of unstable effects and accelerated heart rate of atropine eye drops are solved, stable treatment and reduction of myopia are achieved, and an effective treatment is provided. The radical cure for myopia.

CN118903125APending Publication Date: 2024-11-08徐萌
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411295267.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-17
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing technology is difficult to completely cure myopia. Although atropine eye drops can prevent myopia, their effects are unstable and cause side effects of accelerating heart rate, affecting the treatment effect.

Method used

The combination of topikaamine eye drops and rosuvastatin calcium tablets was used. Topikaamine was dripped into the eyelids before going to bed. The next day, the rosuvastatin calcium tablets were taken in six times. The dosage was adjusted to reduce adverse heart rate reactions. Fix the ciliary muscle to regulate the paralysis effect.

Benefits of technology

It effectively reduces the adverse reactions of heart rate increase caused by atropine drugs, ensures the stability of the ciliary muscle regulating paralysis, shortens the treatment time, and gradually reduces the degree of myopia.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a method for treating myopia. According to the method, myopia can be effectively treated, safety is achieved, no obvious side effect exists, and good clinical application prospects are achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to a drug and method for treating myopia, and belongs to the field of medical technology. Background Art

[0002] Epidemiological data show that the prevalence of myopia and high myopia in China and even in the world continues to rise. The increasing popularity of electronic products such as computers and mobile phones is one of the main reasons for the younger and more severe myopia. High myopia will significantly increase the prevalence of ophthalmic diseases. Therefore, it is urgent to find a new method for treating myopia. The present invention will propose a new method for treating myopia to completely cure myopia. Summary of the invention

[0003] A method for treating myopia, namely, using tropicamide eye drops in combination with rosuvastatin calcium tablets. The tropicamide eye drops are used before bedtime, dripped into the eyelid, 1 drop at a time, and then dripped a second time after an interval of 5 minutes. The rosuvastatin calcium tablets are used during the day of the next day, with a dosage of 60 mg / day, divided into six doses, 10 mg each time, with an interval of about 2 hours between each two doses. The medication is continuously used in this manner. DETAILED DESCRIPTION

[0004] The following is a detailed description of this method.

[0005] Unless otherwise specified, the experimental methods used in the following are all conventional methods. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial sources.

[0006] The medical community generally believes that the cause of myopia is related to ciliary muscle spasm and accommodation tension. Long-term accommodation tension leads to myopia. In recent years, some experiments have shown that 0.01% atropine eye drops can prevent myopia in adolescents, but it cannot cure true myopia that has already formed. I think the idea of ​​using atropine drugs to regulate ciliary muscle paralysis and thus treat myopia is correct. The reason why vision has not improved is that the accommodative paralysis effect of atropine drugs on the ciliary body is not "fixed". As the effect of the drug disappears, the ciliary body returns to the "spasmodic" state. Even if atropine eye drops only act on the eyeball, they can still cause adverse reactions throughout the body. For example, they can relieve the inhibition of the vagus nerve on the heart and accelerate the heart rate. I believe that when using atropine eye drops, their positive effect on the regulation and paralysis of the ciliary muscle coexists with the side effect of causing the heart rate to accelerate. If there is another drug that can lower the heart rate and is used at the same time as atropine eye drops so that the heart rate can be kept within the normal range, then the regulation and paralysis of the ciliary muscle by atropine eye drops can be "fixed", thereby treating myopia.

[0007] Since the commonly used 0.01% atropine eye drops have a long duration of action and can easily affect normal life the next day, tropicamide eye drops are used instead. Two drops are applied before going to bed, and the regulating paralysis effect will basically disappear the next day, without affecting normal life. Rosuvastatin calcium tablets are used as heart rate lowering drugs. Although rosuvastatin calcium tablets do not have a clear effect of lowering heart rate, I have found through experiments that rosuvastatin calcium tablets can effectively reduce the adverse reactions of increased heart rate caused by atropine drugs such as tropicamide eye drops. Unlike commonly used loral drugs, the heart rate lowering effect of rosuvastatin calcium tablets will not cause rebound due to drug discontinuation, and its mechanism of action is still unclear. Rosuvastatin calcium tablets combined with tropicamide eye drops can "fix" the regulating paralysis effect of tropicamide eye drops and relieve ciliary muscle spasm. The commonly used dosage of rosuvastatin calcium tablets is 5mg-20mg per day. Experiments have found that the "heart rate lowering" effect of rosuvastatin calcium tablets increases with increasing dosage, so rosuvastatin calcium tablets are adjusted to 60mg / day to ensure treatment efficiency and thus shorten the treatment time.

[0008] Detailed explanation of the actual treatment process: Drugs or equipment: Rosuvastatin calcium tablets, tropicamide eye drops, and myopia glasses.

[0009] Drug dosage ratio: Use tropicamide eye drops before bedtime, drop into the eyelid, 1 drop at a time, and then drop the second time after 5 minutes. Use rosuvastatin calcium tablets during the day of the next day, the dosage is 60 mg / day, divided into six doses, 10 mg each time, about 2 hours apart between each two doses. Look into the distance more during the day to promote the recovery of the ciliary muscle's regulatory ability. Continue to use the medication according to this method.

[0010] Treatment process: Continue to use according to the above dosage, and the degree will decrease by about 25 degrees per week. When the degree decreases, replace the myopia glasses in time to prevent hyperopia.

Claims

1. A method for treating myopia, characterized in that Tropicamide eye drops are used in combination with rosuvastatin calcium tablets. Tropicamide eye drops are used before bedtime, instilled into the eyelid, 1 drop at a time, and then the second drop is made after an interval of 5 minutes. Rosuvastatin calcium tablets are used during the day of the next day, with a dose of 60 mg / day, divided into six doses, 10 mg each time, with an interval of about 2 hours between each two doses. Continue to use the medication according to this method.